Catechins in tea suppress the activity of cytochrome P450 1A1 through the aryl hydrocarbon receptor activation pathway in rat livers

被引:13
|
作者
Fukuda, Itsuko [1 ]
Nishiumi, Shin [2 ]
Mukai, Rie [2 ]
Yoshida, Ken-ichi [2 ]
Ashida, Hitoshi [2 ]
机构
[1] Kobe Univ, Grad Sch Agr Sci, Res Ctr Food Safety & Secur, Kobe, Hyogo 6578501, Japan
[2] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Div Appl Chem Biosci, Kobe, Hyogo 6578501, Japan
关键词
Aryl hydrocarbon receptor; catechin; cytochrome P450 1As; tea; ACCELERATES DIOXIN EXCRETION; DRUG-METABOLIZING-ENZYMES; LIQUID-CHROMATOGRAPHY; ETHANOLIC EXTRACTS; OXIDATIVE STRESS; TRANSFORMATION; GREEN; EXPRESSION; GENE; POLYPHENOLS;
D O I
10.3109/09637486.2014.992007
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Polycyclic aromatic hydrocarbons (PAHs) and halogenated aromatic hydrocarbons (HAHs) develop various adverse effects through activation of an aryl hydrocarbon receptor (AhR). The suppressive effects of brewed green tea and black tea on 3-methylcholanthrene (MC)-induced AhR activation and its downstream events were examined in the liver of rats. Ad-libitum drinking of green tea and black tea suppressed MC-induced AhR activation and elevation of ethoxyresorufin O-deethylase activity in the liver, whereas the teas themselves did not induce them. Tea showed a suppressive fashion on the expression of cytochrome P450 1A1 (CYP1A1). Tea suppressed the AhR activation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) ex vivo. A part of catechins and theaflavins was present in plasma and liver as conjugated and intact forms. The results of this study suggested that active component(s) of tea are incorporated in the liver and suppress the activity of CYP1As through the AhR activation pathway.
引用
收藏
页码:300 / 307
页数:8
相关论文
共 50 条
  • [1] Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity
    Ciolino, HP
    Wang, TTY
    Yeh, GC
    CANCER RESEARCH, 1998, 58 (13) : 2754 - 2760
  • [2] Coordinate Regulation of Cytochrome P450 1A1 Expression in Mouse Liver by the Aryl Hydrocarbon Receptor and the β-Catenin Pathway
    Braeuning, Albert
    Koehle, Christoph
    Buchmann, Albrecht
    Schwarz, Michael
    TOXICOLOGICAL SCIENCES, 2011, 122 (01) : 16 - 25
  • [3] Expression and polymorphisms of aryl hydrocarbon receptor and cytochrome P450 1A1 genes in endometrial cancer
    Michalak, M.
    Rubi, B.
    Malkowska, Walczak B.
    Ewa, Nowak-Markwitz
    Paczy, Ski M.
    Trzeciak, W. H.
    TUMOR BIOLOGY, 2006, 27 : 66 - 66
  • [4] Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation
    Al-Dhfyan, Abdullah
    Alhoshani, Ali
    Korashy, Hesham M.
    MOLECULAR CANCER, 2017, 16
  • [5] Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation
    Abdullah Al-Dhfyan
    Ali Alhoshani
    Hesham M. Korashy
    Molecular Cancer, 16
  • [6] Erratum to: Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation
    Abdullah Al-Dhfyan
    Ali Alhoshani
    Hesham M. Korashy
    Molecular Cancer, 16
  • [7] The Function of Cytochrome P450 1A1 Enzyme (CYP1A1) and Aryl Hydrocarbon Receptor (AhR) in the Placenta
    Stejskalova, Lucie
    Pavek, Petr
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (05) : 715 - 730
  • [8] Heteroactivation of cytochrome P450 1A1 by teas and tea polyphenols
    Anger, DL
    Petre, MA
    Crankshaw, DJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (07) : 926 - 933
  • [9] Transcriptional activation of cytochrome P450 1A1 with α-tocopherol
    Yu. A. Sidorova
    A. Yu. Grishanova
    V. V. Lyakhovich
    Bulletin of Experimental Biology and Medicine, 2004, 138 : 233 - 236
  • [10] Transcriptional activation of cytochrome p450 1A1 with α-tocopherol
    Sidorova, YA
    Grishanova, AY
    Lyakhovich, VV
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2004, 138 (03) : 233 - 236